415 related articles for article (PubMed ID: 28834075)
21. Fasiglifam for glycaemic control in people with type 2 diabetes: A phase III, placebo-controlled study.
Marcinak J; Cao C; Lee D; Ye Z
Diabetes Obes Metab; 2017 Dec; 19(12):1714-1721. PubMed ID: 28493502
[TBL] [Abstract][Full Text] [Related]
22. Metformin extended-release versus immediate-release: An international, randomized, double-blind, head-to-head trial in pharmacotherapy-naïve patients with type 2 diabetes.
Aggarwal N; Singla A; Mathieu C; Montanya E; Pfeiffer AFH; Johnsson E; Zhao J; Iqbal N; Bailey C
Diabetes Obes Metab; 2018 Feb; 20(2):463-467. PubMed ID: 28857388
[TBL] [Abstract][Full Text] [Related]
23. Approaches to rapid acting insulin intensification in patients with type 2 diabetes mellitus not achieving glycemic targets.
Migdal A; Abrahamson M; Peters A; Vint N
Ann Med; 2018 Sep; 50(6):453-460. PubMed ID: 30103624
[TBL] [Abstract][Full Text] [Related]
24. Clinical inertia, reverse clinical inertia, and medication non-adherence in type 2 diabetes.
Giugliano D; Maiorino MI; Bellastella G; Esposito K
J Endocrinol Invest; 2019 May; 42(5):495-503. PubMed ID: 30291589
[TBL] [Abstract][Full Text] [Related]
25. Patient and Provider Factors Affecting Clinical Inertia in Patients With Type 2 Diabetes on Metformin Monotherapy.
Mahabaleshwarkar R; Gohs F; Mulder H; Wilkins N; DeSantis A; Anderson WE; Ejzykowicz F; Rajpathak S; Norton HJ
Clin Ther; 2017 Aug; 39(8):1658-1670.e6. PubMed ID: 28689692
[TBL] [Abstract][Full Text] [Related]
26. [Management of hyperglycaemia in type 2 diabetes: a patient-centered approach].
Scheen AJ; Mathieu C
Rev Med Liege; 2012 Dec; 67(12):623-31. PubMed ID: 23342872
[TBL] [Abstract][Full Text] [Related]
27. Treatment patterns among older patients with type 2 diabetes in the United States: a retrospective cohort study.
Fu H; Curtis BH; Schuster DP; Festa A; Kendall DM
Diabetes Technol Ther; 2014 Dec; 16(12):833-9. PubMed ID: 25068375
[TBL] [Abstract][Full Text] [Related]
28. The effect of adding metformin to insulin therapy for type 1 diabetes mellitus children: A systematic review and meta-analysis.
Al Khalifah RA; Alnhdi A; Alghar H; Alanazi M; Florez ID
Pediatr Diabetes; 2017 Nov; 18(7):664-673. PubMed ID: 28145083
[TBL] [Abstract][Full Text] [Related]
29. Ethnic disparities in initiation and intensification of diabetes treatment in adults with type 2 diabetes in the UK, 1990-2017: A cohort study.
Mathur R; Farmer RE; Eastwood SV; Chaturvedi N; Douglas I; Smeeth L
PLoS Med; 2020 May; 17(5):e1003106. PubMed ID: 32413037
[TBL] [Abstract][Full Text] [Related]
30. Treatment of periodontal disease for glycaemic control in people with diabetes mellitus.
Simpson TC; Weldon JC; Worthington HV; Needleman I; Wild SH; Moles DR; Stevenson B; Furness S; Iheozor-Ejiofor Z
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD004714. PubMed ID: 26545069
[TBL] [Abstract][Full Text] [Related]
31. Outcomes and treatment patterns of adding a third agent to 2 OADs in patients with type 2 diabetes.
Levin PA; Wei W; Zhou S; Xie L; Baser O
J Manag Care Spec Pharm; 2014 May; 20(5):501-12. PubMed ID: 24761822
[TBL] [Abstract][Full Text] [Related]
32. Apparent subadditivity of the efficacy of initial combination treatments for type 2 diabetes is largely explained by the impact of baseline HbA1c on efficacy.
Polidori D; Capuano G; Qiu R
Diabetes Obes Metab; 2016 Apr; 18(4):348-54. PubMed ID: 26661906
[TBL] [Abstract][Full Text] [Related]
33. Effect of exenatide QW or placebo, both added to titrated insulin glargine, in uncontrolled type 2 diabetes: The DURATION-7 randomized study.
Guja C; Frías JP; Somogyi A; Jabbour S; Wang H; Hardy E; Rosenstock J
Diabetes Obes Metab; 2018 Jul; 20(7):1602-1614. PubMed ID: 29473704
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic inertia and intensified treatment in diabetes mellitus prescription patterns: A nationwide population-based study in Taiwan.
Huang LY; Yeh HL; Yang MC; Shau WY; Su S; Lai MS
J Int Med Res; 2016 Dec; 44(6):1263-1271. PubMed ID: 28322095
[TBL] [Abstract][Full Text] [Related]
35. Patterns and trends in insulin intensification among patients with type 2 diabetes: a systematic review.
Polinski JM; Connolly JG; Curtis BH; Seeger JD; Gaskins K; Perez M; Smith BF; Shrank WH
Prim Care Diabetes; 2014 Jul; 8(2):101-9. PubMed ID: 24275103
[TBL] [Abstract][Full Text] [Related]
36. Association of diabetes treatment with long-term glycemic patterns in patients with type 2 diabetes mellitus: A prospective cohort study.
Luo M; Tan CS; Lim WY; Chia KS; Tang WE; Tai ES; Venkataraman K
Diabetes Metab Res Rev; 2019 May; 35(4):e3122. PubMed ID: 30600922
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness and clinical inertia in patients with antidiabetic therapy.
Machado-Duque ME; Ramírez-Riveros AC; Machado-Alba JE
Int J Clin Pract; 2017 Jun; 71(6):. PubMed ID: 28524340
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic inertia in patients with type 2 diabetes treated with non-insulin agents.
Ampudia-Blasco FJ; Palanca A; Trillo JL; Navarro J; Real JT
J Diabetes Complications; 2021 Mar; 35(3):107828. PubMed ID: 33436143
[TBL] [Abstract][Full Text] [Related]
39. Effect of weight reduction on glycated haemoglobin in weight loss trials in patients with type 2 diabetes.
Gummesson A; Nyman E; Knutsson M; Karpefors M
Diabetes Obes Metab; 2017 Sep; 19(9):1295-1305. PubMed ID: 28417575
[TBL] [Abstract][Full Text] [Related]
40. The evaluation of clinical and cost outcomes associated with earlier initiation of insulin in patients with type 2 diabetes mellitus.
Smolen HJ; Murphy DR; Gahn JC; Yu X; Curtis BH
J Manag Care Spec Pharm; 2014 Sep; 20(9):968-84. PubMed ID: 25166296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
